IP Library Assignment 059717/0949
Patent Assignment
Reel/Frame 059717/0949

Assignment of Assignor's Interest

Recorded: 2022-04-29 Pages: 7
Assignors
YU, JI-HOON
Executed: 2022-04-13
IM, CHUN YOUNG
Executed: 2022-04-13
KIM, SO YOUNG
Executed: 2022-04-13
HAN, YE RI
Executed: 2022-04-13
LEE, DOOHYUN
Executed: 2022-04-13
JEON, HUI-JEON
Executed: 2022-04-13
MIN, SANG-HYUN
Executed: 2022-04-13
OH, BAE JUN
Executed: 2022-04-13
PARK, SANG-WOOK
Executed: 2022-04-13
CHOI, DONG-KYU
Executed: 2022-04-13
KIM, YOUNG-KYU
Executed: 2022-04-13
KIM, SUNG HWAN
Executed: 2022-04-13
LEE, YURI
Executed: 2022-04-13
LEE, SEUNGYEON
Executed: 2022-04-13
KIM, NAM HUI
Executed: 2022-04-13
KIM, SANG BUM
Executed: 2022-04-13
MIN, JU-SIK
Executed: 2022-04-13
Assignee
DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
88, DONGNAE-RO, DONG-GU, DAEGU, 41061, KOREA, REPUBLIC OF
Covered Property (1)
Compound Comprising EZH2 Inhibitor and E3 Ligase Binder and Pharmaceutical Composition for Preventing or Treating EZH2-Associated Disease Comprising Same as Active Ingredient
Application: 17/773,325 →
Publication: US 2023/0010508
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
License Jun 26, 2026
From: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
To: ENZYCHEM LIFESCIENCES CORPORATION
Reel/Frame 075108/0679 →